[Successful percutaneous treatment of complex heart disease in a stage IV non-small cell lung cancer survivor].
Autor: | Bosi D; Cardiologia Ospedaliera, Dipartimento di Medicina Specialistica, Azienda USL-IRCCS Reggio Emilia., Demola P; Cardiologia Ospedaliera, Dipartimento di Medicina Specialistica, Azienda USL-IRCCS Reggio Emilia., Alberti G; Oncologia Medica, Dipartimento Oncologico e Terapie Avanzate, Azienda USL-IRCCS Reggio Emilia., Musto D'Amore S; Cardiologia Ospedaliera, Dipartimento di Medicina Specialistica, Azienda USL-IRCCS Reggio Emilia., Larocca M; Oncologia Medica, Dipartimento Oncologico e Terapie Avanzate, Azienda USL-IRCCS Reggio Emilia., Guiducci V; Cardiologia Ospedaliera, Dipartimento di Medicina Specialistica, Azienda USL-IRCCS Reggio Emilia., Pinto C; Oncologia Medica, Dipartimento Oncologico e Terapie Avanzate, Azienda USL-IRCCS Reggio Emilia., Navazio A; Cardiologia Ospedaliera, Dipartimento di Medicina Specialistica, Azienda USL-IRCCS Reggio Emilia., Tarantini L; Cardiologia Ospedaliera, Dipartimento di Medicina Specialistica, Azienda USL-IRCCS Reggio Emilia. |
---|---|
Jazyk: | italština |
Zdroj: | Giornale italiano di cardiologia (2006) [G Ital Cardiol (Rome)] 2024 Oct; Vol. 25 (10), pp. 747-751. |
DOI: | 10.1714/4336.43217 |
Abstrakt: | The presence of metastatic cancer represents a high-risk condition for the treatment of heart disease requiring surgical or percutaneous procedures. We present the case of a 58-year-old man with pulmonary adenocarcinoma and renal metastases surviving more than 3 years after chemotherapy and immunotherapy suffering dyspnea and chest pain on minimal exertion due to 99% anterior coronary artery stenosis associated with severe aortic stenosis of a bicuspid valve. We treated the cardiac lesions in two steps by coronary angioplasty with drug-eluting stent implantation followed by percutaneous prosthetic aortic valve replacement. The procedures were successful with resolution of the symptoms and recovery of the usual ECOG-PS 0-1 functional capacity which persists 24 months after cardiac procedures. This case demonstrates that the multidisciplinary collaboration between oncologists and cardiologists with a personalized patient-centered approach allows to treat complex clinical situations successfully in the emerging category of patients surviving with metastatic cancer. |
Databáze: | MEDLINE |
Externí odkaz: |